Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.

This biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. The ...

Their research led to the development of a drug that nearly doubles the life expectancy for adult cystic fibrosis patients.

IT Concepts, Inc. doing business as Kentro (Kentro hereafter) was awarded a Department of Defense (DoD) National Geospatial-Intelligence Agency (NGA) VERTEX contract providing NGA with program and ...

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 11:30 AM EDT Reshma Kewalramani - CEO, President & Director Duncan J.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year's Lasker~DeBakey Clinical Medical Researc ...

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

Tri Pointe Homes, one of the largest homebuilders in the U.S., has announced that sales have begun at Carlisle, its new ...

A month has gone by since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 6.9% in that time frame, outperforming the S&P 500. But investors have to be wondering, ...

The agency says it’s open to offering speedy approval pathways for new pain medications that can fight the ongoing opioid ...

The landscape of machine learning engineering has evolved dramatically over the past decade, with organizations increasingly ...

The Trump administration is cutting money from programs that have supported minority students, including at other ...